Diabetes, Wheelchair Firms Brace For DME Impact As Rx Bill Goes To Floor

Eleventh-hour efforts by Rep. David Hobson (R-Ohio) to craft language mitigating a reduction in payments for five DME product services appear to have fallen short, as the House and Senate prepare to begin floor debate on the Medicare bill

More from Archive

More from Medtech Insight